REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPathfinder Minerals Regulatory News (PFP)

  • This share is currently suspended. It was suspended at a price of 0.275

Share Price Information for Pathfinder Minerals (PFP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.275
PFP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amendment to the revised IM Minerals SPA

29 Jan 2024 10:21

RNS Number : 2257B
Pathfinder Minerals Plc
29 January 2024

29th January 2024

Pathfinder Minerals plc

("Pathfinder" or the "Company")

Agreed amendment to the revised SPA concerning the sale of IM Minerals

Pathfinder Minerals PLC (AIM: PFP), an AIM Rule 15 cash shell, announces that it has been informed by Acumen Advisory Group LLC ("AAG") that AAG contemplated not complying with the deferred consideration payment terms of the revised sale and purchase agreement in respect of the disposal of IM Minerals Limited ("IMM") (the "Disposal"), and with it, the rights to bring a claim against the Government of Mozambique for the expropriation of Mining Concession 4623C (the "Claim") (together the "Revised SPA"). Details of the Revised SPA was announced by the Company on 28 July 2023, and in this respect, the Disposal completed on 18 August 2023.

In light of the above developments, the directors of the Company (the "Directors") believe that there was a high probability of AAG defaulting on the current terms and conditions of the Revised SPA. Accordingly, to avoid any such default from occurring, and following pre-emptive discussion between Pathfinder and AAG it is now agreed between the parties that certain terms and conditions of the Revised SPA are amended (the "Agreed Amendments").

AAG have confirmed they have submitted the Claim by way of a Request for Arbitration to the International Centre for Settlement of Investment Disputes.

Background to and details of the Agreed Amendments

Pursuant to the Revised SPA it was agreed between Pathfinder and AAG that, inter alia, a contingent payment would be made by AAG to Pathfinder of the greater sum of US$30 million or 25% of the aggregate amount (including all deferred or conditional payments) payable on Claim, less all reasonable costs and expenses properly incurred in respect of the Claim (the "Original Deferred Consideration Clause").

It is now agreed that the Deferred Consideration will be based solely a sliding recovery scale, as outlined below (the "New Deferred Consideration Clause"):

Amount for which Rights Claim Finalised (US$m)

Percentage of Net Recoveries to be paid to Pathfinder

0 - 10m

40.0%

10m - 20m

37.5%

20m - 30m

35.0%

30m - 40m

32.5%

40m - 50m

30.0%

50m - 70m

27.5%

70m - 120m

25.0%

>120m

22.5%

In addition, and separate to the above agreed amendment, the Revised SPA prohibits AAG from assigning/transferring any of its rights under the Revised SPA. In this respect, Pathfinder and AAG now agree to amend this clause as such to allow for AAG to assign/transfer all of their interest in IM Minerals to a new third party entity, Luangwa Resources LLC ("Luangwa") and to allow for Luangwa to perform all of AAG's obligations under the Revised SPA (the "New Assignment Clause"). Notwithstanding this amendment, AAG will continue to guarantee to Pathfinder all of the future obligations of Luangwa under the Revised SPA if and when they become performable in accordance with the Revised SPA.

Reasons in favour of the Agreed Amendments

The Directors recognise that the Original Deferred Consideration Clause provides limited economic exposure to AAG in the event that the Claim results in an award lower than US$30 million. As a result, the Directors believe that the agreed New Deferred Consideration Clause will offer AAG economic exposure to the Claim in all situations, provided that a successful monetary award is made pursuant to the Claim.

Without such economic exposure, the Directors believe that AAG had limited incentive to pursue the Claim and would have likely defaulted on the Revised SPA. Defaulting on the Revised SPA would mean that Pathfinder would likely fail to benefit from any future potential successful Claim. With this in mind, the Directors believe that it was not in the best interest of the Company's shareholders to pursue any legal claim against AAG and in this respect, believe that the Agreed Amendments are the most pragmatic way forward to resolve any risk of AAG default. Similarly, agreeing to the New Assignment Clause will result in the introduction of Luangwa. Luangwa are a Delaware-registered entity, independent of AAG. The Directors believe that with Luangwa performing all of AAG's obligations under the Revised SPA, there will now be an amicable way forward towards pursuing the Claim.

Paul Barrett, Executive Director of Pathfinder, said 'I am pleased that the claim has been submitted and the process is now fully underway. There were commercial wrinkles in the original agreement with AAG which have now been ironed out and we look forward to the claim progressing though the system and rewarding shareholders for their patience in this matter.'

Enquiries:

Pathfinder Minerals Plc

Paul Barrett, Executive Director

Tel. +44 (0)20 3143 6748

Allenby Capital Limited (Nominated Adviser and Broker)

John Depasquale / Vivek Bhardwaj (Corporate Finance)

Stefano Aquilino / Joscelin Pinnington (Sales & Corporate Broking)

Tel. +44 (0)20 3328 5656

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCEAEFNAAELEFA
Date   Source Headline
10th Apr 20193:49 pmRNSCorporate Update | Subscription & Issue of Equity
11th Feb 20197:00 amRNSCorporate Update
7th Nov 201811:57 amRNSHolding(s) in Company
5th Nov 20187:00 amRNSHolding(s) in Company
1st Nov 201811:52 amRNSResult of AGM
23rd Oct 20187:00 amRNSIssue of Equity
21st Sep 20187:01 amRNSGrant of Share Options
21st Sep 20187:00 amRNSHalf-year Results
20th Aug 20187:00 amRNSDirectorate Change
10th Aug 20187:00 amRNSAppointment of NOMAD/Broker & Directorate Changes
2nd Jul 20183:37 pmRNSHolding(s) in Company
28th Jun 20187:00 amRNSFinal Results
8th Jun 201811:00 amRNSPrice Monitoring Extension
8th Jun 20188:57 amRNSUpdate Re. Mozambique Supreme Court
17th May 201812:28 pmRNSHolding(s) in Company
17th May 201811:04 amRNSTransaction with a Related Party
16th May 20188:42 amRNSHolding(s) in Company
10th May 20187:00 amRNSGeneral Meeting Requisition Withdrawal
9th May 20185:13 pmRNSIssue of Equity & Proposed Board Changes
24th Apr 20187:00 amRNSRequisitioned General Meeting-Posting of Circular
19th Apr 20184:32 pmRNSUpdate on Requisition to Convene a General Meeting
12th Apr 20185:40 pmRNSFurther Re. Placing
4th Apr 20185:30 pmRNSUpdate on Requisition to Convene a General Meeting
29th Mar 20188:59 amRNSRequisition to Convene a General Meeting
26th Mar 201811:18 amRNSUpdate on Requisition to Convene a General Meeting
26th Mar 201810:01 amRNSResponse to Speculation
21st Mar 20187:00 amRNSRequisition to Convene a General Meeting
2nd Mar 201812:44 pmRNSStatement RE: Broker
26th Feb 20187:00 amRNSCompany Update
21st Feb 20187:00 amRNSCompany Update
22nd Dec 201712:26 pmRNSIssue of Equity
20th Dec 201711:30 amRNSHolding(s) in Company
6th Dec 20175:53 pmRNSHolding(s) in Company
1st Dec 20172:07 pmRNSIssue of Equity
8th Nov 20172:50 pmRNSResult of AGM
19th Oct 20173:15 pmRNSUpdate on Mozambique Court Proceedings
29th Sep 20174:41 pmRNSHolding(s) in Company
28th Sep 20177:00 amRNSHalf-year Report
21st Sep 20177:00 amRNSIssue of Equity
20th Sep 20177:00 amRNSCompany Update
28th Jun 20177:00 amRNSFinal Results
1st Mar 20172:40 pmRNSIssue of Equity
12th Dec 20165:01 pmRNSFurther re. enforcement of English costs orders
1st Dec 20167:00 amRNSIssue of Equity
23rd Nov 20164:23 pmRNSHolding(s) in Company
16th Nov 20161:00 pmRNSGrant of Share Options
15th Nov 20167:00 amRNSFurther re. enforcement of English costs orders
14th Nov 201611:36 amRNSResult of AGM
23rd Sep 20167:00 amRNSHalf-year Report
26th Aug 20167:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.